You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Topical diclofenac improved pain and physical function with no systemic side effects in primary osteoarthritis of the knee

Article Text

Article menu
Download PDFPDF
Therapeutics
Topical diclofenac improved pain and physical function with no systemic side effects in primary osteoarthritis of the knee

https://doi.org/10.1136/ebm.10.3.81

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004;171:333–8.
    OpenUrlAbstract/FREE Full Text

    
 
 Q In patients with primary osteoarthritis (OA) of the knee, is a topical diclofenac (TD) solution more effective than topical vehicle control (VC) or placebo for providing symptom relief?

    Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Rheumatology ★★★★★☆☆ Internal Medicine ★★★★★★★

    METHODS

    Embedded ImageDesign:

    randomised vehicle and placebo controlled trial.

    Embedded ImageAllocation:

    concealed.*

    Embedded ImageBlinding:

    blinded (patients, healthcare providers, data collectors, and outcome assessors).*

    Embedded ImageFollow up period:

    28 days.

    Embedded ImageSetting:

    7 medical centres in Ontario, Canada.

    Embedded ImagePatients:

    248 patients who were 18–80 years of age (63% women, mean age 62 y) and had primary OA in ⩾1 knee (verified radiologically within the previous 6 mo) and at least moderate pain (identified with the Western Ontario and McMaster Universities [WOMAC] LK3.0 OA Index pain subscale). Exclusion criteria included secondary arthritis related to syphilitic …

    View Full Text

    Footnotes

    • ↵* *See glossary.

    • For correspondence: Dr. J Z Shainhouse, Dimethaid Health Care Ltd, Markham, Ontario, Canada. Fax 905 415 0827

    • Source of funding: Dimethaid Health Care.